News Pacira CEO hopes for further expansion to US nerve block lab... CEO wants "broad nerve block label" for Exparel
News FDA approves Indivior's long-lasting opioid withdrawal thera... Monthly injection will help addicts manage withdrawal symptoms
News FDA encourages cheap abuse-deterrent painkillers Regulator waiting for non-opioid alternatives to reach the market
News Daiichi Sankyo denies AstraZeneca takeover report Japanese pharma also hands back rights to painkiller to US biotech.
News Praxis soars on rare childhood epilepsy trial data Praxis looks like it could be filing for approval of two products next year, after its childhood epilepsy drug delivered a win in a pivotal trial.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
